Five things worth knowing before you compare products

• Route beats dose. A 20 mg pouch and a 20 mg vape pod do not deliver nicotine at the same speed or efficiency.
• Lungs are the fastest doorway. Inhaled nicotine can reach the brain in about 10 to 20 seconds, close to an intravenous dose.
• Oral products are slower but steadier. Pouches, gums and lozenges work through the mouth lining over 20 to 30 minutes.
• Formulation matters. Nicotine salts feel smoother than freebase at the same strength, which changes how people puff.
• Throat hit is not a dose meter. A harsh hit does not prove a higher blood level of nicotine.

Nicotine is absorbed wherever it can cross a mucous membrane or the alveolar wall of the lungs. Its behaviour depends on the pH of the environment and the surface area available. In the deep lung, the alveoli offer roughly the surface of a tennis court, and the blood-air barrier is only microns thick. That is why inhaled aerosols and smoke deliver nicotine so quickly, according to published pharmacokinetic reviews.

The mouth and nose behave differently. The oral mucosa absorbs nicotine well only when the pH is slightly alkaline, so gums and pouches are buffered to make the nicotine molecule un-ionised and lipid-soluble. Swallowed nicotine, by contrast, is largely broken down by the liver on first pass, which is why chewing and swallowing a nicotine gum wastes most of the dose.

Once nicotine crosses into blood, it reaches the brain within seconds if it entered through the lungs, or within many minutes if it came through the cheek or gum line. That single difference in timing, more than the milligrams on the label, is what makes each product feel like its own thing.

Four factors do most of the work. The first is formulation. Freebase nicotine is alkaline and harsh, which limits how much a user can comfortably inhale, especially at strengths above 6 mg/ml. Nicotine salts, made by pairing nicotine with a mild organic acid such as benzoic acid, lower the pH of the aerosol and reduce throat irritation. That is why 20 mg/ml salt pods, the ceiling under the UAE’s ESMA vape regulations, feel gentler than a 6 mg/ml freebase juice at the same puff length.

The second factor is the device. Higher wattage mods produce larger aerosol droplets and more vapour, but droplet size matters more than cloud size for how deep the nicotine reaches. Smaller particles settle in the alveoli; larger particles land in the throat and upper airways, where absorption is slower and less complete.

The third factor is the human. Puff duration, inhalation depth and mouth-to-lung versus direct-lung style all shift the delivered dose. Genetics also play a role: the CYP2A6 enzyme metabolises nicotine, and people with faster variants clear it more quickly, which is documented in clinical genetics literature. Two people using the same pod can end up with quite different blood levels an hour later.

Cigarettes remain the fastest and most efficient nicotine delivery device ever engineered, peaking in blood plasma within about five minutes of the first puff. That speed is a large part of why they are so habit-forming, not the total dose. E-cigarettes sit close behind: modern pod systems using salts can approach cigarette-like peaks in experienced users, while older freebase tanks tend to plateau lower.

Heated tobacco products, which warm rather than burn a tobacco stick, land in the middle. They deliver less nicotine per session than a cigarette but faster than a pouch. Nicotine pouches, popular across the GCC as a discreet option, produce a slower rise over 20 to 40 minutes and a longer tail, which some users find easier to control. If you want to compare devices side by side before you commit, you can buy a vape online in Dubai from a licensed local retailer and read the strength and formulation on the label rather than guessing.

Nicotine replacement therapies (NRT) sit at the mild end. Patches release a steady low dose over hours; gums and lozenges give a modest bump over 20 minutes. They are effective for quitting precisely because they do not reproduce the sharp peak that reinforces the smoking habit, as covered in WHO tobacco guidance.

Before 2015 or so, vaping meant freebase juice in refillable tanks. Strengths above 12 mg/ml were unpleasant, so heavy smokers often struggled to switch. The introduction of nicotine salt formulations solved the harshness problem and let small, low-power pod devices deliver satisfying doses at 20, 30 or (outside the UAE) 50 mg/ml.

The result is a device that behaves more like a cigarette in terms of the sensory loop: quick draw, quick satisfaction, put it away. It is also why cloud-chasing sub-ohm setups have shrunk as a share of the market, replaced by pocket-sized pods that most casual users prefer.